Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVLP
2026
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $2.57M | ﹤0.01% |
+331,332
| New | +$2.65M |
|
2027
LivaNova
LIVN
$4.41B
| $2.55M | ﹤0.01% |
27,926
-182,658
| -87% | -$19.6M |
|
2028
Interparfums
IPAR
$3.76B
| $2.54M | ﹤0.01% |
38,789
+34,759
| +863% | +$2.09M |
|
2029
Hudbay
HBM
$13.5B
| $2.54M | ﹤0.01% |
538,118
-535,784
| -50% | -$2.52M |
|
2030
PUT
Johnson & Johnson
JNJ
$640B
| $2.54M | ﹤0.01% |
20,000
-20,000
| -50% | -$2.79M |
|
2031
Gerdau
GGB
$9.22B
| $2.54M | ﹤0.01% |
849,946
+637,583
| +300% | +$2.07M |
|
2032
Mammoth Energy Services
TUSK
$152M
| $2.53M | ﹤0.01% |
140,697
-312,262
| -69% | -$7.67M |
|
2033
CGI
GIB
$15.4B
| $2.52M | ﹤0.01% |
41,181
-20,366
| -33% | -$1.26M |
|
2034
iShares S&P 500 Growth ETF
IVW
$77.2B
| $2.52M | ﹤0.01% |
66,892
+52,880
| +377% | +$2.14M |
|
2035
Avista
AVA
$3.16B
| $2.52M | ﹤0.01% |
59,289
+44,778
| +309% | +$2.22M |
|
2036
FirstService
FSV
$6.16B
| $2.52M | ﹤0.01% |
36,743
+6,451
| +21% | +$482K |
|
|
MRC
2037
DELISTED
MRC Global
MRC
| $2.51M | ﹤0.01% |
205,296
-352,148
| -63% | -$5.57M |
|
|
NEBUU
2038
DELISTED
Nebula Acquisition Corporation Unit
NEBUU
| $2.51M | ﹤0.01% |
250,000
| – | – |
|
2039
Bath & Body Works
BBWI
$3.76B
| $2.51M | ﹤0.01% |
120,908
-622,428
| -84% | -$15.7M |
|
2040
American Water Works
AWK
$27.2B
| $2.51M | ﹤0.01% |
+27,618
| New | +$2.52M |
|
|
MODN
2041
DELISTED
MODEL N, INC.
MODN
| $2.51M | ﹤0.01% |
189,531
-365,927
| -66% | -$5.28M |
|
|
EBSB
2042
DELISTED
Meridian Bancorp, Inc.
EBSB
| $2.51M | ﹤0.01% |
175,013
-118,345
| -40% | -$1.86M |
|
2043
Turkcell
TKC
$4.7B
| $2.5M | ﹤0.01% |
445,592
+224,565
| +102% | +$1.19M |
|
|
HUYA
2044
Huya Inc
HUYA
$493M
| $2.5M | ﹤0.01% |
161,333
+133,546
| +481% | +$2.48M |
|
|
DISH
2045
CALL
DELISTED
DISH Network Corp.
DISH
| $2.5M | ﹤0.01% |
100,000
-75,000
| -43% | -$2.35M |
|
|
FITB
2046
Fifth Third Bancorp
FITB
$49.7B
| $2.49M | ﹤0.01% |
105,951
-1,363,410
| -93% | -$35.9M |
|
|
PCMI
2047
DELISTED
PCM, Inc
PCMI
| $2.49M | ﹤0.01% |
141,147
-131,027
| -48% | -$2.38M |
|
|
FIT
2048
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.48M | ﹤0.01% |
+500,000
| New | +$2.58M |
|
|
TPC
2049
Tutor Perini Cor
TPC
$4.83B
| $2.48M | ﹤0.01% |
+155,265
| New | +$2.7M |
|
2050
iShares Latin America 40 ETF
ILF
$3.76B
| $2.48M | ﹤0.01% |
80,436
-93,997
| -54% | -$3.02M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.